SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Courtesy of AbbVie

469

AbbVie

ABBV

U.S.

The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.

CEO

Richard A. Gonzalez

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

North Chicago, IL

Employees

28,000

Years on Global 500 List

1

Key Financials (last fiscal year)
($ Millions)% change
Revenues ($M)$22,85914.5%
Profits ($M)$5,144190.0%
Assets ($M)$53,050
Total Stockholder Equity ($M)$3,945
Profit Ratios
Profit as % of Revenues22.5%
Profits as % of Assets9.7%
Profits as % of Stockholder Equity130.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AbbVie

AbbVie Gets OK for Potential Blockbuster Endometriosis Treatment

AbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis.

Read More →
Could a New Immunotherapy Medical Approach Break the Alzheimer's Drug Curse?

AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.

Read More →

Videos about AbbVie